Triple
T15614024
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | United States federal drug laws |
E375367
|
entity |
| Predicate | includes |
P1393
|
FINISHED |
| Object | Federal Food Drug and Cosmetic Act |
E31160
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Federal Food Drug and Cosmetic Act | Statement: [United States federal drug laws, includes, Federal Food Drug and Cosmetic Act]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Federal Food Drug and Cosmetic Act Context triple: [United States federal drug laws, includes, Federal Food Drug and Cosmetic Act]
-
A.
Federal Food, Drug, and Cosmetic Act
chosen
The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
-
B.
Kefauver–Harris Drug Amendments of 1962
The Kefauver–Harris Drug Amendments of 1962 are U.S. federal regulations that strengthened drug safety and efficacy requirements, mandating proof of effectiveness and stricter oversight of pharmaceutical marketing and manufacturing.
-
C.
Prescription Drug Marketing Act
The Prescription Drug Marketing Act is a U.S. federal law that regulates the distribution and marketing of prescription drugs to ensure their safety, effectiveness, and integrity within the pharmaceutical supply chain.
-
D.
Food and Drug Administration Modernization Act of 1997
The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
-
E.
Food and Drug Administration Amendments Act of 2007
The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d85ccf2794819096cda4cbcb02d478 |
completed | April 10, 2026, 2:13 a.m. |
| NER | Named-entity recognition | batch_69e04e83407c8190abbcd4b7fab0ff85 |
completed | April 16, 2026, 2:50 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ff56d91f208190a11f0d208970145b |
completed | May 9, 2026, 3:46 p.m. |
Created at: April 10, 2026, 4:13 a.m.